Company intelligence / Profile preview

Hartington Pharmaceuticals

Barcelona, Spainhartington.org ↗
Ownership
Private
Development stage
Other
01

Overview

Hartington Pharmaceuticals is dedicated to the development and production of innovative, natural substance-derived pharmaceutical products, managing clinical trials, manufacturing, and regulatory tasks through subsidiaries in Spain, the UK, and Georgia. The company positions itself as a future leader in phytopharmaceuticals and aspires to global recognition for its efficacy and safety.

Therapeutic areas
OncologyPulmonologyDermatologyRheumatology
Modalities
Small moleculeBiologicPhytopharmaceutical (natural substance-based drugs)
Industry
Biotech
02

Drug pipeline

1 asset

Chronos-X

Preclinical

Beyond the preview

Go deeper on Hartington Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hartington Pharmaceuticals.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call